首页 > 最新文献

ARYA Atherosclerosis最新文献

英文 中文
Delayed coronary air embolism post re-do mitral valve replacement: A case report. 二尖瓣置换术后迟发性冠状动脉空气栓塞1例。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.41928.2910
Pouya Nezafati, Sumit Yadav

Background: Coronary air embolism (CAE) is a complication that can lead to catastrophic outcomes, including myocardial infarction, stroke, and death. It is reported to occur during cardiac catheterization, within a few hours after cardiac surgery, or as a result of chest trauma. This is a case report of delayed coronary air embolism following cardiac surgery.

Case presentation: A 58-year-old female presented with New York Heart Association (NYHA) Class II symptoms resulting from severe, highly eccentric anterior mitral regurgitation from a bio-prosthetic valve. She had preserved ejection function and a total calcium score of zero. This patient underwent a re-do mechanical mitral valve replacement. Two days post-surgery, she was brought to the catheterization laboratory with signs and symptoms suggestive of an inferior myocardial infarction (MI) and complete heart block (CHB). Her symptoms and ST changes resolved immediately after the introduction of angiographic contrast. Angiography revealed no occlusion in the right coronary artery (RCA).

背景:冠状动脉空气栓塞(CAE)是一种并发症,可导致灾难性的后果,包括心肌梗死、中风和死亡。据报道,它发生在心导管插入术中,心脏手术后几小时内,或由于胸部创伤。本文报告一例心脏手术后迟发性冠状动脉空气栓塞。病例介绍:一名58岁女性,因生物瓣膜植入导致严重、高度偏心二尖瓣前返流而出现纽约心脏协会(NYHA) II级症状。她保留了射血功能,总钙评分为零。该患者接受了二次机械二尖瓣置换术。术后2天,患者被带到导管实验室,体征和症状提示下型心肌梗死(MI)和完全性心脏传导阻滞(CHB)。她的症状和ST改变在引入血管造影后立即消失。血管造影显示右冠状动脉(RCA)无闭塞。
{"title":"Delayed coronary air embolism post re-do mitral valve replacement: A case report.","authors":"Pouya Nezafati, Sumit Yadav","doi":"10.48305/arya.2024.41928.2910","DOIUrl":"10.48305/arya.2024.41928.2910","url":null,"abstract":"<p><strong>Background: </strong>Coronary air embolism (CAE) is a complication that can lead to catastrophic outcomes, including myocardial infarction, stroke, and death. It is reported to occur during cardiac catheterization, within a few hours after cardiac surgery, or as a result of chest trauma. This is a case report of delayed coronary air embolism following cardiac surgery.</p><p><strong>Case presentation: </strong>A 58-year-old female presented with New York Heart Association (NYHA) Class II symptoms resulting from severe, highly eccentric anterior mitral regurgitation from a bio-prosthetic valve. She had preserved ejection function and a total calcium score of zero. This patient underwent a re-do mechanical mitral valve replacement. Two days post-surgery, she was brought to the catheterization laboratory with signs and symptoms suggestive of an inferior myocardial infarction (MI) and complete heart block (CHB). Her symptoms and ST changes resolved immediately after the introduction of angiographic contrast. Angiography revealed no occlusion in the right coronary artery (RCA).</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 3","pages":"1-6"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of high intensity interval vs. low intensity continuous training on LXRβ, ABCG5 and ABCG8 genes expression in male wistar rats. 高强度间歇与低强度连续训练对雄性wistar大鼠LXRβ、ABCG5和ABCG8基因表达的影响
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.42635.2961
Sediqeh Jalali

Background: Liver X receptors (LXR) play an essential role in the regulation of cholesterol metabolism, and their activation increases ABCG5 and ABCG8 gene expression for the improvement of cholesterol excretion from the body during reverse cholesterol transport (RCT). The aim of this study was to investigate the effects of high-intensity interval (HIT) and low-intensity continuous (LIT) trainings on gene expression of these substances after a high-fat diet in Wistar rats.

Methods: Fifteen male Wistar rats were divided into 3 groups: control group (n = 5), HIT exercise group (n = 5), and LIT exercise group (n = 5). All groups were fed a high-fat diet for 13 weeks, and the HIT and LIT groups performed the specific training program. The expression of LXRβ, ABCG5, and ABCG8 genes was measured after the training period.

Results: Data analysis showed significantly higher levels of LXRβ, ABCG5, and ABCG8 gene expression in the HIT and LIT groups compared to the control group (P ≤ 0.05).

Conclusion: HIT and LIT trainings after a high-fat diet have beneficial effects on RCT, preventing heart attacks. Additionally, HIT training may have a greater effect on cholesterol excretion during the reverse cholesterol transport mechanism than LIT.

背景:肝脏X受体(Liver X receptors, LXR)在胆固醇代谢调控中发挥重要作用,其激活可增加ABCG5和ABCG8基因表达,从而改善体内胆固醇在逆向转运(RCT)过程中的排泄。本研究旨在探讨高脂饮食后高强度间歇训练(HIT)和低强度连续训练(LIT)对Wistar大鼠这些物质基因表达的影响。方法:15只雄性Wistar大鼠分为3组:对照组(n = 5)、HIT运动组(n = 5)和LIT运动组(n = 5),各组饲喂高脂饲料13周,HIT组和LIT组分别进行特定的训练方案。训练结束后检测LXRβ、ABCG5和ABCG8基因的表达。结果:数据分析显示,HIT组和LIT组LXRβ、ABCG5、ABCG8基因表达水平显著高于对照组(P≤0.05)。结论:高脂饮食后的HIT和LIT训练对RCT有有益的预防心脏病发作的作用。此外,在胆固醇逆向转运机制中,HIT训练对胆固醇排泄的影响可能比LIT更大。
{"title":"Effects of high intensity interval vs. low intensity continuous training on LXRβ, ABCG5 and ABCG8 genes expression in male wistar rats.","authors":"Sediqeh Jalali","doi":"10.48305/arya.2024.42635.2961","DOIUrl":"10.48305/arya.2024.42635.2961","url":null,"abstract":"<p><strong>Background: </strong>Liver X receptors (LXR) play an essential role in the regulation of cholesterol metabolism, and their activation increases ABCG5 and ABCG8 gene expression for the improvement of cholesterol excretion from the body during reverse cholesterol transport (RCT). The aim of this study was to investigate the effects of high-intensity interval (HIT) and low-intensity continuous (LIT) trainings on gene expression of these substances after a high-fat diet in Wistar rats.</p><p><strong>Methods: </strong>Fifteen male Wistar rats were divided into 3 groups: control group (n = 5), HIT exercise group (n = 5), and LIT exercise group (n = 5). All groups were fed a high-fat diet for 13 weeks, and the HIT and LIT groups performed the specific training program. The expression of LXRβ, ABCG5, and ABCG8 genes was measured after the training period.</p><p><strong>Results: </strong>Data analysis showed significantly higher levels of LXRβ, ABCG5, and ABCG8 gene expression in the HIT and LIT groups compared to the control group (P ≤ 0.05).</p><p><strong>Conclusion: </strong>HIT and LIT trainings after a high-fat diet have beneficial effects on RCT, preventing heart attacks. Additionally, HIT training may have a greater effect on cholesterol excretion during the reverse cholesterol transport mechanism than LIT.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 6","pages":"27-33"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional analysis on hypertension: Exploring the impact of lifestyle modifications and antihypertensive drug adherence in Sudan. 高血压横断面分析:探讨苏丹生活方式改变和抗高血压药物依从性的影响。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.42582.2952
Amani Ahmed, Hind A Rikabi, Samreen Soomro, Abd El-Karim Em, S H Estabrag, Ali Elham A

Background: Sudan has a high prevalence of hypertension or high blood pressure, a key risk factor for cardiovascular illnesses. Therefore, this study aimed to investigate the socio-demographic characteristics, antihypertensive medication adherence, lifestyle changes, and the relationships between these factors and blood pressure control.

Methods: A cross-sectional study was conducted from March to August 2023 in tertiary care hospitals in Sudan. A structured questionnaire was used to gather information from 385 hypertensive individuals who participated in the study.

Results: The results estimated a positive correlation between the independent variables measuring medication adherence. Diet, stress management, and exercise also moderately correlated with each other and the independent variables. Systolic and diastolic blood pressure levels had a high correlation at 0.93, and most variables correlated moderately with the dependent variable of blood pressure control. The regression model (R = 0.698) using the dependent variable (blood pressure control) as the outcome strongly correlated with the independent variables, explaining almost 49% of the variance in hypertension control. It was observed that blood pressure control was significantly predicted by adherence to antihypertensive medication, proper diet, exercise, and stress reduction among the participants.

Conclusion: The study emphasizes the significance of lifestyle changes for effective hypertension control, specifically adherence to antihypertensive medication, diet, exercise, and stress management. Hypertensive patients in Sudan experienced much better blood pressure control and a decreased risk of cardiovascular problems after changing their lifestyle.

背景:苏丹的高血压患病率很高,这是心血管疾病的一个关键危险因素。因此,本研究旨在探讨社会人口学特征、降压药依从性、生活方式改变以及这些因素与血压控制的关系。方法:于2023年3月至8月在苏丹三级保健医院进行横断面研究。一份结构化问卷收集了385名参与研究的高血压患者的信息。结果:结果估计测量药物依从性的自变量之间存在正相关。饮食、压力管理和锻炼也有一定的相关性。收缩压和舒张压水平的相关性为0.93,大多数变量与血压控制的因变量有中等相关性。以因变量(血压控制)为结果的回归模型(R = 0.698)与自变量强相关,解释了高血压控制方差的近49%。研究发现,参与者坚持服用抗高血压药物、适当饮食、锻炼和减轻压力,可以显著预测血压的控制。结论:该研究强调了生活方式改变对有效控制高血压的重要性,特别是坚持抗高血压药物、饮食、运动和压力管理。苏丹的高血压患者在改变生活方式后,血压控制得更好,患心血管疾病的风险也降低了。
{"title":"A cross-sectional analysis on hypertension: Exploring the impact of lifestyle modifications and antihypertensive drug adherence in Sudan.","authors":"Amani Ahmed, Hind A Rikabi, Samreen Soomro, Abd El-Karim Em, S H Estabrag, Ali Elham A","doi":"10.48305/arya.2024.42582.2952","DOIUrl":"10.48305/arya.2024.42582.2952","url":null,"abstract":"<p><strong>Background: </strong>Sudan has a high prevalence of hypertension or high blood pressure, a key risk factor for cardiovascular illnesses. Therefore, this study aimed to investigate the socio-demographic characteristics, antihypertensive medication adherence, lifestyle changes, and the relationships between these factors and blood pressure control.</p><p><strong>Methods: </strong>A cross-sectional study was conducted from March to August 2023 in tertiary care hospitals in Sudan. A structured questionnaire was used to gather information from 385 hypertensive individuals who participated in the study.</p><p><strong>Results: </strong>The results estimated a positive correlation between the independent variables measuring medication adherence. Diet, stress management, and exercise also moderately correlated with each other and the independent variables. Systolic and diastolic blood pressure levels had a high correlation at 0.93, and most variables correlated moderately with the dependent variable of blood pressure control. The regression model (R = 0.698) using the dependent variable (blood pressure control) as the outcome strongly correlated with the independent variables, explaining almost 49% of the variance in hypertension control. It was observed that blood pressure control was significantly predicted by adherence to antihypertensive medication, proper diet, exercise, and stress reduction among the participants.</p><p><strong>Conclusion: </strong>The study emphasizes the significance of lifestyle changes for effective hypertension control, specifically adherence to antihypertensive medication, diet, exercise, and stress management. Hypertensive patients in Sudan experienced much better blood pressure control and a decreased risk of cardiovascular problems after changing their lifestyle.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 5","pages":"38-45"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between simple electrocardiographic parameter and paroxysmal atrial fibrillation. 单纯心电图参数与阵发性心房颤动的关系。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.41690.2900
Mohammad Assadian Rad, Hanie Shadrou, Sajad Kazemalilou, Habib Eslami Kenarsari, Mahboobeh Gholipour

Background: Atrial fibrillation (AF) is a prevalent arrhythmia, and predicting its occurrence plays a crucial role in reducing its complications. This study aimed to investigate the relation between simple P wave parameters and paroxysmal AF (pAF).

Methods: In this case-control study, demographic and laboratory data were gathered by a checklist. P wave parameters were measured in electrocardiography (ECG). The relationship between these parameters and AF in groups was analyzed.

Results: Eighty individuals were included (40 patients with pAF (57.5% female, mean age = 64.9 ± 2.04) and 40 individuals without AF (57.5% female, mean age = 60.3 ± 2.01)). The P wave peak time (PWPT) in leads D2 (p = 0.003) and V1 (p = 0.001) were longer in the case group. In addition, the prolongation of the PR interval (PR) in lead D2, P wave duration (PWD) in lead D2, and P terminal force (PTF) in V1 were associated with an increase in the occurrence of pAF. Adjusted regression analysis showed that two variables, PWPT in V1 (OR, 95% CI: 1.04 (1.01-1.07), p = 0.005) and PWD in D2 (OR, 95% CI: 1.03 (1.00-1.05), p = 0.018), were predictors for AF.

Conclusion: Our results underscore the potential utility of simple ECG parameters, especially PWD in lead D2 and PWPT in V1, in predicting and assessing the risk of pAF. These findings provide valuable insights for clinical practice and risk stratification in patients without structural cardiac disease. Additionally, these findings may potentially contribute to the prevention of complications and injuries associated with pAF.

背景:心房颤动(AF)是一种常见的心律失常,预测其发生对减少其并发症起着至关重要的作用。本研究旨在探讨简单P波参数与阵发性房颤(pAF)的关系。方法:在本病例对照研究中,采用核对表收集人口统计学和实验室资料。测量心电图P波参数。分析各组各参数与房颤的关系。结果:共纳入80例患者,其中pAF患者40例(女性57.5%,平均年龄64.9±2.04),无AF患者40例(女性57.5%,平均年龄60.3±2.01)。病例组D2导联(P = 0.003)和V1导联(P = 0.001) P波峰值时间(PWPT)更长。此外,D2导联PR间隔(PR)延长、D2导联P波持续时间(PWD)延长、V1 P末端力(PTF)延长与pAF发生增加有关。校正回归分析显示,V1期PWPT (OR, 95% CI: 1.04 (1.01-1.07), p = 0.005)和D2期PWD (OR, 95% CI: 1.03 (1.00-1.05), p = 0.018)是af的预测因子。结论:我们的结果强调了简单心电图参数,特别是D2导联PWD和V1期PWPT在预测和评估pAF风险方面的潜在效用。这些发现为无结构性心脏病患者的临床实践和风险分层提供了有价值的见解。此外,这些发现可能有助于预防与pAF相关的并发症和损伤。
{"title":"Relationship between simple electrocardiographic parameter and paroxysmal atrial fibrillation.","authors":"Mohammad Assadian Rad, Hanie Shadrou, Sajad Kazemalilou, Habib Eslami Kenarsari, Mahboobeh Gholipour","doi":"10.48305/arya.2024.41690.2900","DOIUrl":"10.48305/arya.2024.41690.2900","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is a prevalent arrhythmia, and predicting its occurrence plays a crucial role in reducing its complications. This study aimed to investigate the relation between simple P wave parameters and paroxysmal AF (pAF).</p><p><strong>Methods: </strong>In this case-control study, demographic and laboratory data were gathered by a checklist. P wave parameters were measured in electrocardiography (ECG). The relationship between these parameters and AF in groups was analyzed.</p><p><strong>Results: </strong>Eighty individuals were included (40 patients with pAF (57.5% female, mean age = 64.9 ± 2.04) and 40 individuals without AF (57.5% female, mean age = 60.3 ± 2.01)). The P wave peak time (PWPT) in leads D2 (p = 0.003) and V1 (p = 0.001) were longer in the case group. In addition, the prolongation of the PR interval (PR) in lead D2, P wave duration (PWD) in lead D2, and P terminal force (PTF) in V1 were associated with an increase in the occurrence of pAF. Adjusted regression analysis showed that two variables, PWPT in V1 (OR, 95% CI: 1.04 (1.01-1.07), p = 0.005) and PWD in D2 (OR, 95% CI: 1.03 (1.00-1.05), p = 0.018), were predictors for AF.</p><p><strong>Conclusion: </strong>Our results underscore the potential utility of simple ECG parameters, especially PWD in lead D2 and PWPT in V1, in predicting and assessing the risk of pAF. These findings provide valuable insights for clinical practice and risk stratification in patients without structural cardiac disease. Additionally, these findings may potentially contribute to the prevention of complications and injuries associated with pAF.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 5","pages":"6-14"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-hospital mortality of acute ST-elevation myocardial infarction (STEMI) and its predictors-using Yazd Cardiovascular Diseases Registry, YCDR. 急性st段抬高型心肌梗死(STEMI)的住院死亡率及其预测因子——基于Yazd心血管疾病登记处(YCDR)
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.42893.2985
Mohsen Mohammadi, Seyedeh Mahdieh Namayandeh, Masoud Mirzaei, Mohsen Askari Shahi, Seyed Mahmoud Sadr Bafighi, Hamidreza Dehghan

Background: The purpose of this study was estimate and identify in hospital mortality predictors factors for patients with acute ST elevation myocardial infarction (STEMI).

Methods: This study is a retrospective cohort study based on data from the Yazd Cardiovascular Diseases Registry (YCDR) from 2015-2018 in Yazd Province, Iran, focusing on hospitalized patients with ST-elevation myocardial infarction (STEMI). The primary outcome was in-hospital mortality in STEMI patients. A total of 1861 patients with STEMI were analyzed. Multivariable logistic regression was used to determine death predictive factors for in-hospital mortality in STEMI patients. The significance level of the model was considered to be 5% and the software was used for analysis.

Results: The study included 1,861 patients with STEMI. Among them, 103 (5.5%) individuals died during admission the hospital. After multivariable logistic regression, the following variables were identified as death predictive factors for in-hospital mortality of STEMI: having a history of CVA (OR: 5.6, 95% CI: 2.2-20.3), killip class IV (OR: 6.4, 95%CI: 1.5-11.2), lower ejection fraction (OR: 3.6, 95% CI: 1.2-9.8), lower HDL cholesterol (OR: 1.2, 95% CI: 1.01-2.3), and lower hemoglobin (OR: 1.4, 95% CI: 1.3-2.9).

Conclusion: This study found that lower ejection fraction, lower hemoglobin levels, Killip class IV, having a history of CVA, and low HDL cholesterol levels are important death predictive factors for hospital mortality in patients with STEMI. Health policy in STEMI management must consider these factors to improve hospital prognosis.

背景:本研究的目的是估计并确定急性 ST 型抬高心肌梗死(STEMI)患者的住院死亡率预测因素:本研究的目的是估算并确定急性ST段抬高型心肌梗死(STEMI)患者的住院死亡率预测因素:本研究是一项回顾性队列研究,基于伊朗亚兹德省亚兹德心血管疾病登记处(YCDR)2015-2018年的数据,重点关注ST段抬高型心肌梗死(STEMI)住院患者。主要结果是 STEMI 患者的院内死亡率。共分析了 1861 名 STEMI 患者。多变量逻辑回归用于确定 STEMI 患者院内死亡率的死亡预测因素。模型的显著性水平被认为是5%,并使用软件进行分析:研究纳入了 1861 名 STEMI 患者。其中,103人(5.5%)在入院期间死亡。经过多变量逻辑回归,以下变量被确定为 STEMI 院内死亡的预测因素:有 CVA 病史(OR:5.6,95% CI:2.2-20.3)、killip 分级 IV 级(OR:5.6,95% CI:2.2-20.3)、CVA 病史(OR:5.6,95% CI:2.2-20.33)、killip 分级 IV(OR:6.4,95%CI:1.5-11.2)、射血分数较低(OR:3.6,95%CI:1.2-9.8)、高密度脂蛋白胆固醇较低(OR:1.2,95%CI:1.01-2.3)和血红蛋白较低(OR:1.4,95%CI:1.3-2.9):本研究发现,射血分数较低、血红蛋白水平较低、Killip 分级 IV、有 CVA 病史和高密度脂蛋白胆固醇水平较低是 STEMI 患者住院死亡率的重要死亡预测因素。STEMI 管理方面的卫生政策必须考虑这些因素,以改善住院预后。
{"title":"In-hospital mortality of acute ST-elevation myocardial infarction (STEMI) and its predictors-using Yazd Cardiovascular Diseases Registry, YCDR.","authors":"Mohsen Mohammadi, Seyedeh Mahdieh Namayandeh, Masoud Mirzaei, Mohsen Askari Shahi, Seyed Mahmoud Sadr Bafighi, Hamidreza Dehghan","doi":"10.48305/arya.2024.42893.2985","DOIUrl":"10.48305/arya.2024.42893.2985","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was estimate and identify in hospital mortality predictors factors for patients with acute ST elevation myocardial infarction (STEMI).</p><p><strong>Methods: </strong>This study is a retrospective cohort study based on data from the Yazd Cardiovascular Diseases Registry (YCDR) from 2015-2018 in Yazd Province, Iran, focusing on hospitalized patients with ST-elevation myocardial infarction (STEMI). The primary outcome was in-hospital mortality in STEMI patients. A total of 1861 patients with STEMI were analyzed. Multivariable logistic regression was used to determine death predictive factors for in-hospital mortality in STEMI patients. The significance level of the model was considered to be 5% and the software was used for analysis.</p><p><strong>Results: </strong>The study included 1,861 patients with STEMI. Among them, 103 (5.5%) individuals died during admission the hospital. After multivariable logistic regression, the following variables were identified as death predictive factors for in-hospital mortality of STEMI: having a history of CVA (OR: 5.6, 95% CI: 2.2-20.3), killip class IV (OR: 6.4, 95%CI: 1.5-11.2), lower ejection fraction (OR: 3.6, 95% CI: 1.2-9.8), lower HDL cholesterol (OR: 1.2, 95% CI: 1.01-2.3), and lower hemoglobin (OR: 1.4, 95% CI: 1.3-2.9).</p><p><strong>Conclusion: </strong>This study found that lower ejection fraction, lower hemoglobin levels, Killip class IV, having a history of CVA, and low HDL cholesterol levels are important death predictive factors for hospital mortality in patients with STEMI. Health policy in STEMI management must consider these factors to improve hospital prognosis.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 6","pages":"6-16"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of ECG findings in COVID-19 patients: Predictor of in-hospital prognosis. COVID-19 患者心电图结果的重要性:院内预后的预测因素。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2023.41600.2887
Mahsa Behnemoon, Mojhdeh Mehrno, Vahid Alinejad

Background: Cardiac injury in COVID-19 patients confers a worse prognosis. The interpretation of electrocardiography can be beneficial in the early diagnosis of probable cardiac involvement. After adjusting for other variables, we sought to determine if the initial ECG on admission could add additional prognostic value.

Methods: In this single-center cross-sectional study, 1165 patients with a positive COVID-19 PCR between Feb 2020 and Nov 2021 were enrolled in our study. Patients were grouped according to their admitted units, and survivors to hospital discharge or non-survivors. Predictors of ICU admission and in-hospital mortality were determined using univariate analysis and a logistic regression model.

Results: The mean age was 55.6 ± 16.2 years and 52% were male. Out of 1165 patients, 149 deaths (12.8%) were recorded during hospitalization. Sinus tachycardia was the most common dysrhythmia, followed by premature atrial and ventricular beats, sinus bradycardia, and atrial fibrillation (28.6%, 5.6%, 3.9%, and 2.1%, respectively). Age (p<0.001), sex (p=0.006), history of diabetes mellitus (p=0.002), hypertension (p=0.018), ischemic heart disease (p=0.004), and cancer (p<0.001) were more frequent among non-survivors. Among ECG findings, tachycardia, low voltage QRS, ST-T changes, and dysrhythmia were related to an increased mortality risk. However, in regression analysis, only sex (OR 1.89, 95% CI 1.2 to 2.9, p=0.004), age (OR 1.03, 95% CI 1.02 to 1.05, p<0.001), and initial tachycardia (OR 1.02, 95% CI 1.01 to 1.03, p<0.001) were independent predictors of in-hospital mortality.

Conclusion: Our data suggest that initial electrocardiographic findings could be helpful in distinguishing patients with an increased risk for ICU admission or in-hospital death.

背景:COVID-19 患者的心脏损伤会导致预后恶化。心电图的解读有助于早期诊断可能的心脏受累。在对其他变量进行调整后,我们试图确定入院时的初始心电图是否能增加预后价值:在这项单中心横断面研究中,我们纳入了在 2020 年 2 月至 2021 年 11 月期间 COVID-19 PCR 呈阳性的 1165 例患者。患者根据入院单位、出院后存活或未存活进行分组。采用单变量分析和逻辑回归模型确定了入住重症监护室和院内死亡率的预测因素:平均年龄为 55.6 ± 16.2 岁,52% 为男性。在 1165 名患者中,有 149 人(12.8%)在住院期间死亡。窦性心动过速是最常见的心律失常,其次是房性早搏和室性早搏、窦性心动过缓和心房颤动(分别占 28.6%、5.6%、3.9% 和 2.1%)。年龄(p结论:我们的数据表明,最初的心电图检查结果有助于区分入住重症监护室或院内死亡风险增加的患者。
{"title":"Importance of ECG findings in COVID-19 patients: Predictor of in-hospital prognosis.","authors":"Mahsa Behnemoon, Mojhdeh Mehrno, Vahid Alinejad","doi":"10.48305/arya.2023.41600.2887","DOIUrl":"10.48305/arya.2023.41600.2887","url":null,"abstract":"<p><strong>Background: </strong>Cardiac injury in COVID-19 patients confers a worse prognosis. The interpretation of electrocardiography can be beneficial in the early diagnosis of probable cardiac involvement. After adjusting for other variables, we sought to determine if the initial ECG on admission could add additional prognostic value.</p><p><strong>Methods: </strong>In this single-center cross-sectional study, 1165 patients with a positive COVID-19 PCR between Feb 2020 and Nov 2021 were enrolled in our study. Patients were grouped according to their admitted units, and survivors to hospital discharge or non-survivors. Predictors of ICU admission and in-hospital mortality were determined using univariate analysis and a logistic regression model.</p><p><strong>Results: </strong>The mean age was 55.6 ± 16.2 years and 52% were male. Out of 1165 patients, 149 deaths (12.8%) were recorded during hospitalization. Sinus tachycardia was the most common dysrhythmia, followed by premature atrial and ventricular beats, sinus bradycardia, and atrial fibrillation (28.6%, 5.6%, 3.9%, and 2.1%, respectively). Age (p<0.001), sex (p=0.006), history of diabetes mellitus (p=0.002), hypertension (p=0.018), ischemic heart disease (p=0.004), and cancer (p<0.001) were more frequent among non-survivors. Among ECG findings, tachycardia, low voltage QRS, ST-T changes, and dysrhythmia were related to an increased mortality risk. However, in regression analysis, only sex (OR 1.89, 95% CI 1.2 to 2.9, p=0.004), age (OR 1.03, 95% CI 1.02 to 1.05, p<0.001), and initial tachycardia (OR 1.02, 95% CI 1.01 to 1.03, p<0.001) were independent predictors of in-hospital mortality.</p><p><strong>Conclusion: </strong>Our data suggest that initial electrocardiographic findings could be helpful in distinguishing patients with an increased risk for ICU admission or in-hospital death.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 1","pages":"41-50"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease. 提高心脏病患者服药依从性的移动应用程序的开发和疗效。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.42169.2924
Raziyeh Ghafouri, Roxana Karbaschi, AliReza Mashhadi Hosein, Shakila Sharifian

Background: Patients with cardiovascular disease need to adhere to their treatment and care recommendations to prevent the progression of their condition and improve their quality of life. In this regard, this study was conducted to develop a mobile application and test its effectiveness in improving medication adherence among persons with cardiac disease.

Methods: The study was conducted in two stages. The first stage involved the preparation of the "Mobile Application for Persons with Cardiac Disease" using the cascade model. In the second stage, 121 patients who were hospitalized in the cardiac intensive care unit of Ayatollah Taleghani Medical Education Center of Tehran from March to August 2023 were enrolled. The participants were randomly assigned to either the control group (63 people) or the intervention group (58 people). The study collected data using a medication adherence questionnaire on the 7th, 14th, and 21st day after discharge and compared the results with the control group. The data were analyzed using SPSS 20.

Results: The average age of the control group was 56.75 ± 11.38 years, and the average age of the intervention group was 57.03 ± 11.55 years. The comparison of the average medication adherence with independent t-tests showed a significant difference between the intervention and control groups on the 7th, 14th, and 21st day after discharge (P<0.01). The results of the repeated measures test in each group also showed that the difference between the groups increased over time (P<0.001).

Conclusion: The results of the study showed that the mobile application is effective in improving medication adherence among heart patients.

背景:心血管疾病患者需要坚持他们的治疗和护理建议,以防止病情的进展,提高他们的生活质量。在这方面,本研究是为了开发一个移动应用程序,并测试其在改善心脏病患者服药依从性方面的有效性。方法:研究分为两个阶段进行。第一阶段涉及使用级联模型编制“心脏病患者移动应用程序”。在第二阶段,纳入了2023年3月至8月在德黑兰阿亚图拉塔莱格尼医学教育中心心脏重症监护病房住院的121名患者。参与者被随机分配到对照组(63人)或干预组(58人)。本研究于出院后第7、14、21天采用药物依从性问卷收集数据,并与对照组进行比较。数据采用SPSS 20进行分析。结果:对照组患者平均年龄56.75±11.38岁,干预组患者平均年龄57.03±11.55岁。通过独立t检验比较干预组与对照组在出院后第7、14、21天的平均服药依从性差异有统计学意义(p)。结论:研究结果表明,移动应用程序对改善心脏病患者的服药依从性是有效的。
{"title":"Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease.","authors":"Raziyeh Ghafouri, Roxana Karbaschi, AliReza Mashhadi Hosein, Shakila Sharifian","doi":"10.48305/arya.2024.42169.2924","DOIUrl":"10.48305/arya.2024.42169.2924","url":null,"abstract":"<p><strong>Background: </strong>Patients with cardiovascular disease need to adhere to their treatment and care recommendations to prevent the progression of their condition and improve their quality of life. In this regard, this study was conducted to develop a mobile application and test its effectiveness in improving medication adherence among persons with cardiac disease.</p><p><strong>Methods: </strong>The study was conducted in two stages. The first stage involved the preparation of the \"Mobile Application for Persons with Cardiac Disease\" using the cascade model. In the second stage, 121 patients who were hospitalized in the cardiac intensive care unit of Ayatollah Taleghani Medical Education Center of Tehran from March to August 2023 were enrolled. The participants were randomly assigned to either the control group (63 people) or the intervention group (58 people). The study collected data using a medication adherence questionnaire on the 7th, 14th, and 21st day after discharge and compared the results with the control group. The data were analyzed using SPSS 20.</p><p><strong>Results: </strong>The average age of the control group was 56.75 ± 11.38 years, and the average age of the intervention group was 57.03 ± 11.55 years. The comparison of the average medication adherence with independent t-tests showed a significant difference between the intervention and control groups on the 7th, 14th, and 21st day after discharge (P<0.01). The results of the repeated measures test in each group also showed that the difference between the groups increased over time (P<0.001).</p><p><strong>Conclusion: </strong>The results of the study showed that the mobile application is effective in improving medication adherence among heart patients.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 3","pages":"28-36"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical performance and safety of the Vector® percutaneous transluminal coronary angioplasty balloon catheter: A single-arm, multicenter, retrospective post-marketing clinical study. Vector®经皮冠状动脉腔内成形术球囊导管的临床性能和安全性:单臂、多中心、回顾性上市后临床研究
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.42702.2971
Preeti Vani, Arvind Patel, Kumar Abhishek, Kailash Goyal

Background: The present post-marketing clinical study was conducted over a 12-month follow-up period to monitor the clinical outcomes of patients treated with the Vector® Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter for the dilatation of coronary lesions. The semi-compliant balloon improves balloon-to-vessel wall apposition and minimizes balloon slippage during PTCA, which could reduce complications and improve clinical outcomes. This investigation aimed to assess the safety and effectiveness of the Vector® PTCA Balloon Catheter in real-world settings.

Methods: A retrospective study was conducted to investigate the safety and efficacy of the Vector® PTCA Balloon Catheter in 125 patients who underwent pre-dilatation and post-dilatation. The primary outcome of the study was major adverse cardiac events (MACE), a composite endpoint encompassing target-lesion revascularization (TLR), cardiac death, and myocardial infarction (MI).

Results: The Vector® PTCA Balloon Catheter has shown promising results in a small group of patients undergoing dilatation of normal and intricate coronary artery lesions, reflecting a 100% procedural success rate. The successful delivery to the target lesion, deployment, and subsequent retrieval of the device during the index procedure led to a 100% device success rate without any technical issues. A total of 3.2% (4) patients experienced MACE during the 12-month follow-up, with 1.6% (2) MI, 1.6% (2) TLR, and no cardiovascular deaths..

Conclusion: This study demonstrated the favorable safety and reliability of the Vector® PTCA Balloon Catheter in patients with angina, MI, and a history of coronary artery disease in a real-world setting.

背景:目前的上市后临床研究进行了为期12个月的随访,以监测使用Vector®经皮腔内冠状动脉血管成形术(PTCA)球囊导管治疗冠状动脉病变扩张的患者的临床结果。半顺应性球囊改善了PTCA中球囊与血管壁的贴合,最大限度地减少了球囊滑移,可以减少并发症并改善临床结果。本研究旨在评估Vector®PTCA球囊导管在现实环境中的安全性和有效性。方法:回顾性研究Vector®PTCA球囊导管在125例扩张前和扩张后患者中的安全性和有效性。该研究的主要终点是主要心脏不良事件(MACE),这是一个复合终点,包括靶病变血运重建术(TLR)、心源性死亡和心肌梗死(MI)。结果:Vector®PTCA球囊导管在一小群接受正常和复杂冠状动脉病变扩张的患者中显示出令人鼓舞的结果,反映了100%的手术成功率。在索引过程中,成功地将设备运送到目标病变,部署和随后的设备检索导致设备成功率达到100%,没有任何技术问题。在12个月的随访中,共有3.2%(4)例患者经历了MACE, 1.6%(2)例心肌梗死,1.6%(2)例TLR,无心血管死亡。结论:本研究证明了Vector®PTCA球囊导管在现实世界中对心绞痛、心肌梗死和有冠状动脉疾病史的患者具有良好的安全性和可靠性。
{"title":"Clinical performance and safety of the Vector® percutaneous transluminal coronary angioplasty balloon catheter: A single-arm, multicenter, retrospective post-marketing clinical study.","authors":"Preeti Vani, Arvind Patel, Kumar Abhishek, Kailash Goyal","doi":"10.48305/arya.2024.42702.2971","DOIUrl":"10.48305/arya.2024.42702.2971","url":null,"abstract":"<p><strong>Background: </strong>The present post-marketing clinical study was conducted over a 12-month follow-up period to monitor the clinical outcomes of patients treated with the Vector® Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter for the dilatation of coronary lesions. The semi-compliant balloon improves balloon-to-vessel wall apposition and minimizes balloon slippage during PTCA, which could reduce complications and improve clinical outcomes. This investigation aimed to assess the safety and effectiveness of the Vector® PTCA Balloon Catheter in real-world settings.</p><p><strong>Methods: </strong>A retrospective study was conducted to investigate the safety and efficacy of the Vector® PTCA Balloon Catheter in 125 patients who underwent pre-dilatation and post-dilatation. The primary outcome of the study was major adverse cardiac events (MACE), a composite endpoint encompassing target-lesion revascularization (TLR), cardiac death, and myocardial infarction (MI).</p><p><strong>Results: </strong>The Vector® PTCA Balloon Catheter has shown promising results in a small group of patients undergoing dilatation of normal and intricate coronary artery lesions, reflecting a 100% procedural success rate. The successful delivery to the target lesion, deployment, and subsequent retrieval of the device during the index procedure led to a 100% device success rate without any technical issues. A total of 3.2% (4) patients experienced MACE during the 12-month follow-up, with 1.6% (2) MI, 1.6% (2) TLR, and no cardiovascular deaths..</p><p><strong>Conclusion: </strong>This study demonstrated the favorable safety and reliability of the Vector® PTCA Balloon Catheter in patients with angina, MI, and a history of coronary artery disease in a real-world setting.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 6","pages":"17-26"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-enriched microRNAs as novel biomarkers in atherosclerotic and cardiovascular disease patients. 血小板富集microrna作为动脉粥样硬化和心血管疾病患者的新生物标志物。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2024.41664.2898
Parisa Masoudikabir, Mohammadreza Shirazy, Fatemeh Sigarchian Taghizadeh, Mohamad Esmail Gheydari, Mohsen Hamidpour

Background: Cardiovascular disease (CVD) is a global health challenge. Various studies have shown that genetic and environmental factors play roles in the development and progression of CVD. Small non-coding RNAs, namely microRNAs (miRs), regulate gene expression and have key roles in essential cellular processes such as apoptosis, cell cycle, differentiation, and proliferation. Currently, clinical studies highlight the critical role of platelets and miRs in coronary thrombosis, atherosclerosis, and CVD.

Methods: Using search engines such as PubMed and Scopus, articles studying platelet miRs and their effects on atherosclerosis and cardiovascular disease were reviewed.

Results: This article presents a comprehensive analysis of the association of platelet-related miRs as prognostic, diagnostic, and therapeutic biomarkers with the pathogenesis of atherosclerosis and cardiovascular disease.

Conclusion: Taken together, data show that platelet-related miRs not only play important roles in the initial development of atherosclerosis and cardiovascular disease (CVD), but they are also considered prognostic and diagnostic biomarkers in CVD.

背景:心血管疾病(CVD)是一个全球性的健康挑战。各种研究表明,遗传和环境因素在心血管疾病的发生和发展中起着重要作用。小的非编码rna,即microRNAs (miRs),调节基因表达,在细胞凋亡、细胞周期、分化和增殖等基本细胞过程中发挥关键作用。目前,临床研究强调血小板和mir在冠状动脉血栓形成、动脉粥样硬化和心血管疾病中的关键作用。方法:利用PubMed、Scopus等搜索引擎,对血小板miRs及其对动脉粥样硬化和心血管疾病影响的相关文献进行综述。结果:本文全面分析了血小板相关miRs作为预后、诊断和治疗生物标志物与动脉粥样硬化和心血管疾病发病机制的关系。综上所述,数据显示血小板相关miRs不仅在动脉粥样硬化和心血管疾病(CVD)的初始发展中发挥重要作用,而且还被认为是CVD的预后和诊断生物标志物。
{"title":"Platelet-enriched microRNAs as novel biomarkers in atherosclerotic and cardiovascular disease patients.","authors":"Parisa Masoudikabir, Mohammadreza Shirazy, Fatemeh Sigarchian Taghizadeh, Mohamad Esmail Gheydari, Mohsen Hamidpour","doi":"10.48305/arya.2024.41664.2898","DOIUrl":"10.48305/arya.2024.41664.2898","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) is a global health challenge. Various studies have shown that genetic and environmental factors play roles in the development and progression of CVD. Small non-coding RNAs, namely microRNAs (miRs), regulate gene expression and have key roles in essential cellular processes such as apoptosis, cell cycle, differentiation, and proliferation. Currently, clinical studies highlight the critical role of platelets and miRs in coronary thrombosis, atherosclerosis, and CVD.</p><p><strong>Methods: </strong>Using search engines such as PubMed and Scopus, articles studying platelet miRs and their effects on atherosclerosis and cardiovascular disease were reviewed.</p><p><strong>Results: </strong>This article presents a comprehensive analysis of the association of platelet-related miRs as prognostic, diagnostic, and therapeutic biomarkers with the pathogenesis of atherosclerosis and cardiovascular disease.</p><p><strong>Conclusion: </strong>Taken together, data show that platelet-related miRs not only play important roles in the initial development of atherosclerosis and cardiovascular disease (CVD), but they are also considered prognostic and diagnostic biomarkers in CVD.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 4","pages":"47-67"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the impact of bioenergy economy-based health improvement (BEHI) as a mind-body intervention on laboratory, clinical and psychological factors in post-MI patients: A randomized controlled trial. 评估基于生物能源经济的健康改善(BEHI)作为心身干预对心肌梗死后患者实验室、临床和心理因素的影响:一项随机对照试验
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-01-01 DOI: 10.48305/arya.2023.41115.2847
Mahboubeh Farzanegan, Marsa Sadat Hashemi Jazi, Afsoon Derakhshan Jan, Masoumeh Sadeghi, Hamidreza Roohafza

Background: Patients with ischemic heart disease often exhibit various psychological factors that increase the risk of future cardiovascular events. Therefore, in addition to rehabilitation programs, there is a need for more interventional psychotherapy. Bioenergy Economy-based Health Improvement (BEHI) is a mind-body intervention that may address these issues. This study aimed to evaluate the effectiveness of the BEHI program on laboratory, clinical, and psychological factors in post-myocardial infarction (MI) patients.

Methods: In this study, 52 post-MI patients were randomly divided into two groups. One group received cardiac rehabilitation combined with the BEHI program, while the other group received only cardiac rehabilitation. Laboratory data, clinical characteristics, and psychological variables were evaluated at baseline, immediately after the intervention, and four months post-intervention (follow-up).

Results: Among the participants, the mean age was 59.97 ± 6.32 years, and 98.07% were male. The results showed a significant improvement in the mean scores of metabolic equivalents (METs), depression, and anxiety in participants who received the BEHI program and the rehabilitation program (p values: 0.006, 0.038, and 0.028, respectively).

Conclusion: These findings suggest that incorporating mind-body interventions like the BEHI program into cardiac rehabilitation can enhance physical and psychological outcomes for patients recovering from MI.

背景:缺血性心脏病患者经常表现出各种增加未来心血管事件风险的心理因素。因此,除了康复计划之外,还需要更多的介入性心理治疗。基于生物能源经济的健康改善(BEHI)是一种可能解决这些问题的身心干预。本研究旨在评估BEHI项目对心肌梗死(MI)后患者的实验室、临床和心理因素的影响。方法:本研究将52例心肌梗死后患者随机分为两组。一组接受心脏康复联合BEHI方案,而另一组只接受心脏康复。在基线、干预后立即和干预后4个月(随访)时评估实验室数据、临床特征和心理变量。结果:参与者平均年龄59.97±6.32岁,男性占98.07%。结果显示,接受BEHI计划和康复计划的参与者在代谢当量(METs)、抑郁和焦虑的平均得分方面有显著改善(p值分别为0.006、0.038和0.028)。结论:这些研究结果表明,将心身干预(如BEHI项目)纳入心脏康复可以改善心肌梗死患者的生理和心理结果。
{"title":"Evaluating the impact of bioenergy economy-based health improvement (BEHI) as a mind-body intervention on laboratory, clinical and psychological factors in post-MI patients: A randomized controlled trial.","authors":"Mahboubeh Farzanegan, Marsa Sadat Hashemi Jazi, Afsoon Derakhshan Jan, Masoumeh Sadeghi, Hamidreza Roohafza","doi":"10.48305/arya.2023.41115.2847","DOIUrl":"10.48305/arya.2023.41115.2847","url":null,"abstract":"<p><strong>Background: </strong>Patients with ischemic heart disease often exhibit various psychological factors that increase the risk of future cardiovascular events. Therefore, in addition to rehabilitation programs, there is a need for more interventional psychotherapy. Bioenergy Economy-based Health Improvement (BEHI) is a mind-body intervention that may address these issues. This study aimed to evaluate the effectiveness of the BEHI program on laboratory, clinical, and psychological factors in post-myocardial infarction (MI) patients.</p><p><strong>Methods: </strong>In this study, 52 post-MI patients were randomly divided into two groups. One group received cardiac rehabilitation combined with the BEHI program, while the other group received only cardiac rehabilitation. Laboratory data, clinical characteristics, and psychological variables were evaluated at baseline, immediately after the intervention, and four months post-intervention (follow-up).</p><p><strong>Results: </strong>Among the participants, the mean age was 59.97 ± 6.32 years, and 98.07% were male. The results showed a significant improvement in the mean scores of metabolic equivalents (METs), depression, and anxiety in participants who received the BEHI program and the rehabilitation program (p values: 0.006, 0.038, and 0.028, respectively).</p><p><strong>Conclusion: </strong>These findings suggest that incorporating mind-body interventions like the BEHI program into cardiac rehabilitation can enhance physical and psychological outcomes for patients recovering from MI.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 4","pages":"14-22"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142882597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ARYA Atherosclerosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1